Patients with DEE-associated TRPM3 mutations exhibit a spectrum of neurological and developmental symptoms, including global developmental delay, epilepsy, altered pain perception, and cerebellar abnormalities such as ataxia and hypotonia. This evidence concerns the gene TRPM3 and developmental and epileptic encephalopathy.